Eris Lifesciences Limited (ERIS)

1,269.2

INR
+1.15(+0.09%)
As of March 12, 2025 9:20:00 AM

About Eris Lifesciences Limited

Eris Lifesciences Ltd. is a prominent pharmaceutical company engaged in the development, manufacturing, and distribution of a wide array of pharmaceutical products. Established with the goal of enhancing healthcare accessibility, Eris focuses on various therapeutic areas, including cardiology, diabetology, gastroenterology, and dermatology, providing crucial medications to address lifestyle and chronic conditions. The company plays a significant role in the healthcare industry by innovating and delivering high-quality drug formulations to the market. Based in India, Eris Lifesciences Ltd. caters primarily to domestic demand, but its impact is growing beyond national boundaries as it explores international markets. Known for its robust marketing strategies and strong distribution network, the company effectively reaches healthcare practitioners, ensuring that patients receive timely access to essential medications. Eris Lifesciences Ltd.'s dedication to research and development, combined with a strategic focus on key therapeutic segments, underscores its contribution to advancing medical treatments and improving patient outcomes in the pharmaceutical sector.

RevenueLast 12 months
NA
+NA YoY
EBITDALast 12 months
NA
Price to Sales RatioTTM
6.35
Operating MarginLast 12 months
23.42
+-18.6% quarterly YoY
Market Cap
17287.20 CrINR
Employees
3620
CEO
NA
Website